By Jade Martinez-Pogue ( August 1, 2023, 3:20 PM EDT) -- Clinical-stage oncology company Revolution Medicines Inc., advised by Latham & Watkins LLP, said Tuesday it plans to purchase biopharmaceutical company EQRx Inc., advised by Goodwin Procter LLP, in an all-stock deal that is intended to add over $1 billion in net cash to Revolution Medicines' balance sheet....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.